A case of second degree and typeⅠsinoatrial block caused by lacosamide

doi:10.3877/cma.j.issn.2095-6568.2025.01.006

Chinese Journal of Heart and Heart Rhythm(Electronic Edition) ›› 2025, Vol. 13 ›› Issue (01): 54-56. doi: 10.3877/cma.j.issn.2095-6568.2025.01.006

• Case Report • Previous Articles Next Articles

A case of second degree and typeⅠsinoatrial block caused by lacosamide

Hugen Xu¹, Jia Wang², Fuchi Zhang², Yunshan Zhou², Xiangsong Shi³^,^†()

^1. Department of Internal Medicine， Huai'an Third People's Hospital， Huai'an 223001， China
^2. Department of Psychiatry， Huai'an Third People's Hospital， Huai'an 223001， China
^3. Department of Neurology， Huai'an Third People's Hospital， Huai'an 223001， China

Received:2024-12-20 Online:2025-03-25 Published:2025-04-25
Contact: Xiangsong Shi

Abstract

Hugen Xu, Jia Wang, Fuchi Zhang, Yunshan Zhou, Xiangsong Shi. A case of second degree and typeⅠsinoatrial block caused by lacosamide[J]. Chinese Journal of Heart and Heart Rhythm(Electronic Edition), 2025, 13(01): 54-56.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxzyxldzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-6568.2025.01.006

https://zhxzyxldzzz.cma-cmc.com.cn/EN/Y2025/V13/I01/54

Figures/Tables 2

References 12

［1］	Franco V， French JA， Perucca E. Challenges in the clinical development of new antiepileptic drugs［J］. Pharmacol Res， 2016，103：95-104.
［2］	Hoy SM. Lacosamide：a review in focal-onset seizures in patients with epilepsy［J］. CNS Drugs，2018，32（5）：473-484.
［3］	廖红梅，康庆云，吴丽文，等.拉考沙胺在低龄婴儿钠离子通道相关癫痫中的应用［J］.中华神经科杂志，2022，55（8）：826-833.
［4］	Cawello W， Stockis A， Andreas JO， et al. Advances in epilepsy treatment：lacosamide pharmacokinetic profile［J］. Ann N Y Acad Sci，2014，1329：18-32.
［5］	Farkas V， Steinborn B， Flamini JR， et al. Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures［J］. Neurology， 2019， 93（12）：e1212-e1226.
［6］	Fong SL， Utidjian L， Kaur M， et al. Safety of intravenous lacosamide in hospitalized children and neonates［J］.Epilepsia， 2023，64（9）：2297-2309.
［7］	Babar RK， Bresnahan R， Gillespie CS， et al. Lacosamide add-on therapy for focal epilepsy［J］. Cochrane Database Syst Rev， 2021， 5（5）：CD008841.
［8］	Auvin S， Arzimanoglou A， Beller C， et al. Safety，tolerability， and efficacy of adjunctive lacosamide in pediatric patients with epilepsy syndromes associated with generalized seizures：Phase 2， open-label exploratory trial［J］. Epilepsia， 2023， 64（11）：2947-2957.
［9］	苗婕，孙美珍.拉考沙胺治疗局灶性癫痫的研究进展［J］.中国新药杂志，2019，28（23）：2825-2831.
［10］	Hong Z， Inoue Y， Liao W， et al. Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults：a randomized，double-blind， placebo-controlled study［J］. Epilepsy Res，2016， 127：267-275.
［11］	Labau JIR， Alsaloum M， Estacion M， et al. Lacosamide inhibition of Na（V） 1.7 channels depends on its interaction with the voltage sensor domain and the channel pore［J］. Front Pharmacol， 2021，12：791740.
［12］	Li Y， Guo HL， Wang J， et al. CYP2C19 genotype and sodium channel blockers in lacosamide-treated children with epilepsy：two major determinants of trough lacosamide concentration or clinical response［J］. Ther Adv Neurol Disord， 2024，17：17562864241273087.

Please choose a citation manager

Content to export

A case of second degree and typeⅠsinoatrial block caused by lacosamide

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

Figures/Tables 2

References 12

Related Articles 0

Recommended Articles

Metrics

Comments

模态框（Modal）标题

Please choose a citation manager

Content to export

A case of second degree and typeⅠsinoatrial block caused by lacosamide

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

Figures/Tables 2

References 12

Related Articles 0

Recommended Articles

Metrics

Comments